Successful Spinal Cord Stimulation for Necrotizing Raynaud's Phenomenon in COVID-19 Affected Patient: The Nightmare Comes Back
| Autor: | Antonella Paladini, Ivan Urits, Omar Viswanath, Giustino Varrassi, Martina Rekatsina, Mariateresa Giglio, Filomena Puntillo, Angela Preziosa |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Necrosis spinal cord stimulation medicine.medical_treatment Ischemia Infectious Disease 030204 cardiovascular system & hematology covid-19 pain raynaud phenomenon vascular pain 03 medical and health sciences 0302 clinical medicine Anesthesiology Internal medicine medicine Pain Management business.industry Vascular disease fungi General Engineering Vasospasm medicine.disease Neuromodulation (medicine) Nightmare Peripheral Amputation Cardiology medicine.symptom business 030217 neurology & neurosurgery |
| Zdroj: | Cureus |
| Popis: | Necrotizing Raynaud's phenomenon is a vascular clinical syndrome characterized by vasospasm of distal resistance vessels, usually triggered by cold temperatures or by psychological conditions such as anxiety and stress. Pain is the first reported symptom, related to insufficient oxygen delivery to the extremities that leads to ischemia of the peripheral tissues. The initial treatment is conservative, but if the symptoms persist, necrosis and distal amputation can occur. In selected patients, neuromodulation with spinal cord stimulation (SCS) can be an effective treatment by reducing pain and amputation rate. Recent evidence suggests that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause endotheliopathy with microvascular and macrovascular thrombotic events and can present as a systemic inflammatory vascular disease. We present a case of a severe necrotizing Raynaud's phenomenon successfully treated and controlled with SCS that abruptly reappeared during SARS-CoV-2 infection. The report of this case is suggestive for potential treatment in case of peripheral ischemia consequent to COVID-19 vasculopathy. The interaction between SCS and SARS-CoV-2-related endotheliopathy is unknown and would deserve further studies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|